Company Filing History:
1 out of 504 
1 out of 81 Years Active: 2013
Title: Karl Syson: Innovator in Chemotherapeutic Agents
Introduction
Karl Syson is a notable inventor based in Norwich, GB. He has made significant contributions to the field of chemotherapeutic agents, particularly in methods that target alpha-glucan pathways. His innovative work has the potential to impact the treatment of bacterial infections.
Latest Patents
Karl Syson holds a patent titled "Methods for determining chemotherapeutic agents targeting alpha-glucan pathways and uses thereof." This invention provides methods for determining a putative antibacterial, which includes assessing whether the putative antibacterial inhibits GlgE or Rv3032. The patent also encompasses the antibacterial itself, a pharmaceutical composition, and methods for treating subjects infected with bacteria through the administration of the antibacterial.
Career Highlights
Throughout his career, Karl Syson has worked with esteemed organizations such as the Albert Einstein College of Medicine and Plant Bioscience Limited. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of pharmaceuticals.
Collaborations
Karl has collaborated with notable individuals in his field, including William R Jacobs, Jr. and Rainer Kalscheuer. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Karl Syson's work in developing methods for determining chemotherapeutic agents showcases his dedication to advancing medical science. His contributions have the potential to lead to significant improvements in the treatment of bacterial infections.